Menu
TaeWoong Medical supports the generation of high-quality clinical evidence through collaborative research initiatives. We work with clinicians, hospitals and medical societies to uncover the benefits of TaeWoong technology while maintaining a patient-centric mindset. Examining outcomes data helps generate evidence showing TaeWoong technology value to patients, physicians, and societies.
STARmed technology is the most used device by Key Opinion Leaders around the world to develop procedure standards and establish clinical evidence through peer-reviewed clinical studies. More than 200 articles have been published with STARmed technology to prove the efficacy of this novel treatment in terms of volume reduction rate, symptom relief, cosmetic score and quality of life.
2020 European Thyroid Association Clinical Practice Guideline for the Use of Imaging-Guided Ablation in Benign Thyroid Nodules
European guidelines for the use of thermal ablation in adult patients
Complications Encountered in the Treatment of Benign Thyroid Nodules with US-guided Radiofrequency Ablation
Comparison between complications and treatment effects of conventional thyroidectomy and thyroid thermal ablation showed thyroid thermal ablation as the superior treatment option in terms of patient satisfaction, post-operative quality of life, and shorter hospital stay.
Technique and Procedure Aspects of Radiofrequency Ablation of Thyroid Nodules
Review of basic principles and technical details of thyroid RFA procedure. RFA showed promising results in TNs size reduction as well as cure of hyperthyroidism due to toxic nodules.
Laser Ablation Versus Radiofrequency Ablation for Thyroid Nodules
12-month results of a randomized trial showed RFA persistently achieved a larger VRR than LA at 1-year after treatment, despite the similar technical success rates in both groups.
Radiofrequency ablation (RFA) is a well-established treatment for several benign, premalignant, and malignant disorders. Although the role of RFA has been clearly defined, new indications and applications for endoscopic RFA guided therapies have emerged. RFA has produced promising outcomes in patients with a variety of biliary and pancreatic indications.
EUS-guided radiofrequency ablation of small pancreatic adenocarcinoma
A new therapeutic option for patients unfit for surgery
Endobiliary radiofrequency ablation for distal extrahepatic cholangiocarcinoma
A clinicopathological study to evaluate the actual EB-RFA ablation volume and validated the clinical feasibility of preoperative endobiliary radiofrequency ablation (EB-RFA) for resectable distal extrahepatic cholangiocarcinoma
Feasibility and Safety of Endoluminal Radiofrequency Ablation as a Rescue Treatment for Bilateral Metal Stent Obstruction Due to Tumor Ingrowth in the Hilum
A pilot study aimed to examine the feasibility and safety of endoluminal RFA for occluded bilateral hilar metal stents due to tumor ingrowth in patients with malignant hilar bile duct. obstruction
Therapeutic EUS
Outcomes of EUS-RFA in benign solid pancreatic tumors, pancreas cystic lesions and pancreatic cancer.
Disclosures & Important Safety Information
Patients should talk to their doctor to decide if any TaeWoong Medical USA procedure is right for them. Patients and doctors should review all available information on non-surgical and surgical options and associated risks in order to make an informed decision.
Serious complications may occur in any surgery, including death. Serious risks include, but are not limited to, injury to tissues and organs and conversion to other surgical techniques which could result in a longer operative time and/or increased complications. For Important Safety Information, including surgical risks, indications, and considerations and contraindications for use.
Individuals’ outcomes may depend on a number of factors, including but not limited to patient characteristics, disease characteristics and/or surgeon experience.
STARmed America is bringing our most cutting-edge thermal ablation technology directly to our physicians in North America. Visit our new website to find out more.